Connect Sign In
|
November 7, 2025 |
New Resource Discusses DPYD Genotyping Test Selection, Interpretation The FDA and the National Comprehensive Cancer Network (NCCN) urge DPYD testing before chemotherapy. ARUP |
Visit booth #217 to learn about the latest in genomic sequencing, connect with ARUP’s genetic counselors, and discover educational resources. |
November 4, 2025 |
ARUP Experts Will Highlight the Latest in Genomic Sequencing at NSGC 2025 ARUP experts will highlight the latest in genomic sequencing at the upcoming National Society of Genetic |
Blaine Mathison, BS, M(ASCP), technical director of Parasitology at ARUP, reviews digital images of wet-mount slides. Mathison played a significant role in the validation of the AI screening tool for the detection of gastrointestinal parasites. |
October 21, 2025 |
Journal of Clinical Microbiology Publishes Article on ARUP’s Validation of AI for Parasite… An article describing ARUP’s validation of an artificial intelligence (AI) solution to |
ARUP’s advanced testing and BRCA1 and BRCA2 expertise support patients battling breast cancer and cancer survivors. |
October 14, 2025 |
ARUP Laboratories Supports Patients and Providers During Breast Cancer Awareness Month ARUP supports Breast Cancer Awareness Month with advanced testing, BRCA1 and BRCA2 expertise, and |
The ARUP Clinical Investigations team includes (back row, left to right) Galina Chernova, Kendall Ence, Qian Guo, Stephanie Harrison, and Jacob Brugger; (middle row, left to right) Nicholas Mangome, Chau Trinh, Ani Schjelderup, Carrie Pederson, and Amy Ballard; (front row, left to right) Toni Pollock, Katharina Pennington, Karis Tran, and Rachel Lloyd. |
August 4, 2025 |
ARUP’s Central Pathology Review Service Supports Cogent Biosciences SUMMIT Trial ARUP’s central pathology review service has provided key support for the Cogent SUMMIT trial through robust |
Hepatitis delta virus (HDV), which affects an estimated 48 to 72 million people worldwide, results in the most severe form of viral hepatitis-induced liver disease. |
July 31, 2025 |
ARUP-Validated Assay for Hepatitis D Virus Increases Sensitivity 15-Fold ARUP has launched a highly sensitive and fully automated molecular assay to detect hepatitis delta virus (HDV) |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
Test Information
